These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases. Keren G, Passwell J, Cohen BE. J Med; 1986 Jul 20; 17(5-6):365-71. PubMed ID: 3473170 [Abstract] [Full Text] [Related]
9. Evidence for superantigen mediated process in Kawasaki disease. De Inocencio J, Hirsch R. Arch Dis Child; 1995 Sep 20; 73(3):275-6. PubMed ID: 7492179 [No Abstract] [Full Text] [Related]
10. The pathogenesis of Kawasaki disease and superantigens. Uchiyama T, Kato H. Jpn J Infect Dis; 1999 Aug 20; 52(4):141-5. PubMed ID: 10592892 [Abstract] [Full Text] [Related]
11. Kawasaki disease and toxic shock syndrome--at last the etiology is clear? Curtis N. Adv Exp Med Biol; 2004 Aug 20; 549():191-200. PubMed ID: 15250533 [Abstract] [Full Text] [Related]
13. "Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?". Savaşan S, Warrier I, Can E, Can M, Gedikoğlu G. Med Pediatr Oncol; 1998 Apr 20; 30(4):263-4. PubMed ID: 9473764 [No Abstract] [Full Text] [Related]
14. Superantigens and Kawasaki disease. Furukawa S, Matsubara T, Yabuta K. Immunol Today; 1991 Dec 20; 12(12):464. PubMed ID: 1786081 [No Abstract] [Full Text] [Related]
15. Kawasaki disease or mucocutaneous lymph node syndrome. Has it a microbial aetiology? J Infect; 1984 Jul 20; 9(1):1-5. PubMed ID: 6501892 [No Abstract] [Full Text] [Related]